Drug
Levothyroxine Sodium (LT4) Tablets
Levothyroxine Sodium (LT4) Tablets is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Phase Distribution
Ph phase_4
2
67%
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Not yet recruiting2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (33.3%)
Phase 42 (66.7%)
Trials by Status
completed133%
not_yet_recruiting267%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingphase_2
T4/T3 Therapy in Hypothyroidism
NCT07424183
not_yet_recruitingphase_4
Levothyroxine Intervention in Pregnant Women with TSH （2.5 MIU/L-upper Limit of Reference Range） and Negative Thyroid Peroxidase Antibody
NCT06653907
completedphase_4
Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors
NCT03094416
Clinical Trials (3)
Showing 3 of 3 trials
NCT07424183Phase 2
T4/T3 Therapy in Hypothyroidism
NCT06653907Phase 4
Levothyroxine Intervention in Pregnant Women with TSH （2.5 MIU/L-upper Limit of Reference Range） and Negative Thyroid Peroxidase Antibody
NCT03094416Phase 4
Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3